Consolidated Statements of Income (USD $) In Millions, except Per Share data, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011
Net Sales	$ 14,513	$ 16,046	$ 29,232	$ 30,779
Cost of sales	12,200	13,551	24,485	25,668
Research and development expenses	406	411	811	811
Selling, general and administrative expenses	674	695	1,381	1,395
Amortization of intangibles	122	125	244	248
Restructuring charges	0	0	357	0
Acquisition-related integration expenses	0	0	0	31
Equity in earnings of nonconsolidated affiliates	148	291	317	589
Sundry income (expense) - net	27	80	44	(369)
Interest income	10	10	16	17
Interest expense and amortization of debt discount	312	328	641	705
Income Before Income Taxes	984	1,317	1,690	2,158
Provision for income taxes	244	240	430	360
Net Income	740	1,077	1,260	1,798
Net income attributable to noncontrolling interests	6	10	29	21
Net Income attributable to The Dow Chemical Company	734	1,067	1,231	1,777
Preferred stock dividends	85	85	170	170
Net Income Available for The Dow Chemical Company Common Stockholders	649	982	1,061	1,607
Per Common Share Data:
Earnings per common share - basic	$ 0.55	$ 0.84	$ 0.90	$ 1.39
Earnings per common share - diluted	$ 0.55	$ 0.84	$ 0.90	$ 1.37
Common stock dividends declared per share of common stock	$ 0.32	$ 0.25	$ 0.57	$ 0.40
Weighted-average common shares outstanding - basic	1,169.7	1,149.6	1,165.3	1,144.6
Weighted-average common shares outstanding - diluted	1,176.6	1,160.9	1,172.7	1,156.2
Depreciation	506	526	1,016	1,085
Capital Expenditures	$ 581	$ 564	$ 983	$ 969